Potassium Chloride in Dextrose and Sodium Chloride

Manufacturer: B. Braun Medical Inc.
Effective date: 2024-03-26
Label type: HUMAN PRESCRIPTION DRUG LABEL
Version: 23
Source: full-release
Hydrated at: 2026-05-31 21:01:21

Label at a glance#

ProductPotassium Chloride in Dextrose and Sodium Chloride

Active ingredientDEXTROSE, UNSPECIFIED FORM, SODIUM CHLORIDE, POTASSIUM CHLORIDE

Label structure19 sections

Indications and uses

These intravenous solutions are indicated for use in adults and pediatric patients as sources of electrolytes, calories and water for hydration.

Dosage and administration

These solutions are for intravenous use only. Dosage is to be directed by a physician and is dependent upon age, weight, clinical condition of the patient and laboratory determinations. Frequent laboratory determinations and clinical evaluation are essential to monitor changes in blood glucose and electrolyte concentrations, and fluid and electrolyte balance during prolonged parenteral therapy. When a hypertonic s...

Contacts and useful links#

PhoneLabel contact1-800-227-2862

Label contents#

Full prescribing information#

DESCRIPTION

DESCRIPTION SECTION

(See chart below for quantitative information.)

Potassium Chloride in Dextrose and Sodium Chloride Injections USP are sterile, nonpyrogenic and contain no bacteriostatic or antimicrobial agents. These products are intended for intravenous administration.

The formulas of the active ingredients are:

Ingredients	Molecular Formula	Molecular Weight
Sodium Chloride USP Potassium Chloride USP	NaCl KCl	58.44 74.55

Hydrous Dextrose USP	Chemical Structure	198.17

Not made with natural rubber latex, PVC or DEHP.

The plastic container is made from a multilayered film specifically developed for parenteral drugs. It contains no plasticizers and exhibits virtually no leachables. The solution contact layer is a rubberized copolymer of ethylene and propylene. The container is nontoxic and biologically inert. The container-solution unit is a closed system and is not dependent upon entry of external air during administration. The container is overwrapped to provide protection from the physical environment and to provide an additional moisture barrier when necessary.

Composition – Each 100 mL contains:
Solution	Hydrous Dextrose USP	Sodium Chloride USP	Potassium Chloride USP	Concentration of Electrolytes (mEq/liter)			Calories per liter	Calculated Osmolarity mOsmol/liter	pH
Solution	Hydrous Dextrose USP	Sodium Chloride USP	Potassium Chloride USP	Sodium	Potassium	Chloride	Calories per liter	Calculated Osmolarity mOsmol/liter	pH
Water for Injection USP qs
0.15% Potassium Chloride in 5% Dextrose and 0.20% Sodium Chloride Injection USP	5 g	0.2 g	0.15 g	Sodium	Potassium	Chloride	34	20	54	170	360	4.4 (3.5–6.5)
0.075% Potassium Chloride in 5% Dextrose and 0.45% Sodium Chloride Injection USP	5 g	0.45 g	0.075 g	77	10	87	170	425	4.4 (3.5–6.5)
0.15% Potassium Chloride in 5% Dextrose and 0.45% Sodium Chloride Injection USP	5 g	0.45 g	0.15 g	77	20	97	170	445	4.4 (3.5–6.5)
0.22% Potassium Chloride in 5% Dextrose and 0.45% Sodium Chloride Injection USP	5 g	0.45 g	0.22 g	77	30	107	170	465	4.4 (3.5–6.5)
0.30% Potassium Chloride in 5% Dextrose and 0.45% Sodium Chloride Injection USP	5 g	0.45 g	0.3 g	77	40	117	170	490	4.4 (3.5–6.5)
0.15% Potassium Chloride in 5% Dextrose and 0.9% Sodium Chloride Injection USP	5 g	0.9 g	0.15 g	154	20	174	170	600	4.4 (3.5–6.5)

Addition of medication should be accomplished using complete aseptic technique.

The closure system has two ports; the one for the administration set has a tamper evident plastic protector and the other is a medication addition site. Refer to the Directions for Use of the container.

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

These intravenous solutions provide electrolytes and calories, and are a source of water for hydration. They are capable of inducing diuresis depending on the clinical condition of the patient.

Sodium, the major cation of the extracellular fluid, functions primarily in the control of water distribution, fluid balance, and osmotic pressure of body fluids. Sodium is also associated with chloride and bicarbonate in the regulation of the acid-base equilibrium of body fluid.

Potassium, the principal cation of intracellular fluid, participates in carbohydrate utilization and protein synthesis, and is critical in the regulation of nerve conduction and muscle contraction, particularly in the heart.

Chloride, the major extracellular anion, closely follows the metabolism of sodium, and changes in the acid-base balance of the body are reflected by changes in the chloride concentration.

Dextrose provides a source of calories. Dextrose is readily metabolized, may decrease losses of body protein and nitrogen, promotes glycogen deposition and decreases or prevents ketosis if sufficient doses are provided.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

These intravenous solutions are indicated for use in adults and pediatric patients as sources of electrolytes, calories and water for hydration.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

These solutions are contraindicated where the administration of sodium, potassium or chloride could be clinically detrimental.

Solutions containing dextrose may be contraindicated in patients with hypersensitivity to corn products.

WARNINGS

WARNINGS SECTION

The administration of intravenous solutions can cause fluid and/or solute overload resulting in dilution of serum electrolyte concentrations, overhydration, congested states or pulmonary edema. The risk of dilutional states is inversely proportional to the electrolyte concentration. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentration.

Solutions containing sodium ions should be used with great care, if at all, in patients with congestive heart failure, severe renal insufficiency, and in clinical states in which there is sodium retention with edema.

In patients with diminished renal function, administration of solutions containing sodium or potassium ions may result in sodium or potassium retention.

Solutions containing potassium ions should be used with great care, if at all, in patients with hyperkalemia, severe renal failure, and in conditions in which potassium retention is present.

To avoid life-threatening hyperkalemia, do not administer Potassium Chloride in Dextrose and Sodium Chloride Injections USP as an intravenous push (i.e., intravenous injection manually with a syringe connected to the intravenous access, without a quantitative infusion device).

PRECAUTIONS

PRECAUTIONS SECTION

General

GENERAL PRECAUTIONS SECTION

These solutions should be used with care in patients with hypervolemia, renal insufficiency, urinary tract obstruction, or impending or frank cardiac decompensation.

Extraordinary electrolyte losses such as may occur during protracted nasogastric suction, vomiting, diarrhea or gastrointestinal fistula drainage may necessitate additional electrolyte supplementation.

Additional essential electrolytes, minerals and vitamins should be supplied as needed.

Sodium-containing solutions should be administered with caution to patients receiving corticosteroids or corticotropin, or to other salt-retaining patients.

Care should be exercised in administering solutions containing sodium or potassium to patients with renal or cardiovascular insufficiency, with or without congestive heart failure, particularly if they are postoperative or elderly.

Potassium therapy should be guided primarily by serial electrocardiograms, especially in patients receiving digitalis. Serum potassium levels are not necessarily indicative of tissue potassium levels. Solutions containing potassium should be used with caution in the presence of cardiac disease, particularly when accompanied by renal disease.

Solutions containing dextrose should be used with caution in patients with overt or known subclinical diabetes mellitus, or carbohydrate intolerance for any reason.

To minimize the risk of possible incompatibilities arising from mixing any of these solutions with other additives that may be prescribed, the final infusate should be inspected for cloudiness or precipitation immediately after mixing, prior to administration, and periodically during administration.

Do not use plastic containers in series connection.

If administration is controlled by a pumping device, care must be taken to discontinue pumping action before the container runs dry or air embolism may result. If administration is not controlled by a pumping device, refrain from applying excessive pressure (>300mmHg) causing distortion to the container such as wringing or twisting. Such handling could result in breakage of the container.

These solutions are intended for intravenous administration using sterile equipment. Use only if solution is clear and container and seals are intact.

Laboratory Tests

LABORATORY TESTS SECTION

Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations, and acid-base balance during prolonged parenteral therapy or whenever the condition of the patient warrants such evaluation. Significant deviations from normal concentrations may require tailoring of the electrolyte pattern, in these or alternative solutions.

Carcinogenesis, Mutagenesis, Impairment of Fertility

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

Studies with Potassium Chloride in Dextrose and Sodium Chloride Injections USP have not been performed to evaluate carcinogenic potential, mutagenic potential, or effects on fertility.

Pregnancy

PREGNANCY SECTION

Teratogenic Effects

TERATOGENIC EFFECTS SECTION

Animal reproduction studies have not been conducted with Potassium Chloride in Dextrose and Sodium Chloride Injections USP. It is also not known whether Potassium Chloride in Dextrose and Sodium Chloride Injections USP can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Potassium Chloride in Dextrose and Sodium Chloride Injections USP should be given to a pregnant woman only if clearly needed.

Labor and Delivery

LABOR & DELIVERY SECTION

The effects of Potassium Chloride in Dextrose and Sodium Chloride Injections USP on the duration of labor or delivery, on the possibility that forceps delivery or other intervention or resuscitation of the newborn will be necessary, and on the later growth, development, and functional maturation of the child are unknown.

As reported in the literature, potassium containing solutions have been administered during labor and delivery. Caution should be exercised, and the fluid balance, glucose and electrolyte concentrations, and acid-base balance, of both mother and fetus should be evaluated periodically or whenever warranted by the condition of the patient or fetus.

Nursing Mothers

NURSING MOTHERS SECTION

It is not known whether these drugs are excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Potassium Chloride in Dextrose and Sodium Chloride Injections USP are administered to a nursing woman.

Pediatric Use

PEDIATRIC USE SECTION

Safety and effectiveness of Potassium Chloride in Dextrose and Sodium Chloride Injections USP in pediatric patients have not been established by adequate and well-controlled studies. However, as referenced in the medical literature, potassium chloride injection has been used to treat pediatric patients with potassium deficiency when oral replacement therapy is not feasible.

For patients receiving potassium supplement at greater than maintenance rates, frequent monitoring of serum potassium levels and serial EKGs are recommended.

Dextrose is safe and effective for the stated indications in pediatric patients (see INDICATIONS AND USAGE). As reported in the literature, the dosage selection and constant infusion rate of intravenous dextrose must be selected with caution in pediatric patients, particularly neonates and low birth weight infants, because of the increased risk of hyperglycemia/hypoglycemia. Frequent monitoring of serum glucose concentrations is required when dextrose is prescribed to pediatric patients, particularly neonates and low birth weight infants.

In neonates or in very small infants even small volumes of fluid may affect fluid and electrolyte balance. Care must be exercised in treatment of neonates, especially pre-term neonates, whose renal function may be immature and whose ability to excrete fluid and solute loads may be limited. Fluid intake, urine output, and serum electrolytes should be monitored closely.

See WARNINGS and DOSAGE AND ADMINISTRATION.

Geriatric Use

GERIATRIC USE SECTION

Clinical studies of Potassium Chloride in Dextrose and Sodium Chloride Injections USP did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between elderly and younger patients.

In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.

These drugs are known to be substantially excreted by the kidney, and the risk of toxic reactions to these drugs may be greater in patients with impaired renal function. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function.

See WARNINGS.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation and hypervolemia.

Too rapid infusion of hypertonic solutions may cause local pain and venous irritation. Rate of administration should be adjusted according to tolerance. Use of the largest peripheral vein and a small bore needle is recommended. (See DOSAGE AND ADMINISTRATION.)

Symptoms may result from an excess or deficit of one or more of the ions present in the solution; therefore, frequent monitoring of electrolyte levels is essential.

Hypernatremia may be associated with edema and exacerbation of congestive heart failure due to the retention of water, resulting in an expanded extracellular fluid volume.

Reactions reported with the use of potassium-containing solutions include nausea, vomiting, abdominal pain and diarrhea. The signs and symptoms of potassium intoxication include paresthesias of the extremities, areflexia, muscular or respiratory paralysis, mental confusion, weakness, hypotension, cardiac arrhythmias, heart block, electrocardiographic abnormalities and cardiac arrest.

Potassium deficits result in disruption of neuromuscular function, and intestinal ileus and dilatation.

If infused in large amounts, chloride ions may cause a loss of bicarbonate ions, resulting in an acidifying effect.

The physician should also be alert to the possibility of adverse reaction to drug additives. Prescribing information for drug additives to be administered in this manner should be consulted.

If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.

OVERDOSAGE

OVERDOSAGE SECTION

In the event of fluid overload during parenteral therapy, reevaluate the patient's condition, and institute appropriate corrective treatment.

In the event of overdosage with potassium-containing solutions, discontinue the infusion immediately and institute corrective therapy to reduce serum potassium levels.

Treatment of hyperkalemia includes the following:

Dextrose Injection USP, 10% or 25%, containing 10 units of crystalline insulin per 20 grams of dextrose administered intravenously, 300 to 500 mL per hour.
Absorption and exchange of potassium using sodium or ammonium cycle cation exchange resin, orally and as retention enema.
Hemodialysis and peritoneal dialysis. The use of potassium-containing foods or medications must be eliminated. However, in cases of digitalization, too rapid a lowering of plasma potassium concentration can cause digitalis toxicity.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

These solutions are for intravenous use only.

Dosage is to be directed by a physician and is dependent upon age, weight, clinical condition of the patient and laboratory determinations. Frequent laboratory determinations and clinical evaluation are essential to monitor changes in blood glucose and electrolyte concentrations, and fluid and electrolyte balance during prolonged parenteral therapy.

When a hypertonic solution is to be administered peripherally, it should be slowly infused through a small bore needle, placed well within the lumen of a large vein to minimize venous irritation. Carefully avoid infiltration.

Usually, up to 40 mEq of potassium per liter daily is sufficient to replace normal loss in adults. Typical infusion rates should not exceed 10 mEq per hour or 120 mEq per day. Pediatric patients may require 2 to 3 mEq per kg of body weight daily. See WARNINGS and PRECAUTIONS for pediatric use.

Fluid administration should be based on calculated maintenance or replacement fluid requirements for each patient.

Dextrose may be administered to normal individuals at a rate of 0.5 g/kg/hour without producing glycosuria. At the maximum infusion rate of 0.8 g/kg/hour, approximately 95% of the dextrose is retained.

Potassium Chloride in Dextrose and Sodium Chloride Injections USP should not be administered simultaneously with blood through the same administration set because of the possibility of pseudoagglutination or hemolysis.

Some additives may be incompatible. Consult with pharmacist. When introducing additives, use aseptic techniques. Mix thoroughly. Do not store.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.

HOW SUPPLIED

HOW SUPPLIED SECTION

Potassium Chloride in Dextrose and Sodium Chloride Injections USP are supplied in EXCEL^® Containers. The 1000 mL containers are packaged 12 per case.

Canada DIN	NDC	REF	Size
0.15% Potassium Chloride in 5% Dextrose and 0.20% Sodium Chloride Injection USP (20 mEq K⁺/liter)
01931598	0264-7645-00	L6450	1000 mL
0.075% Potassium Chloride in 5% Dextrose and 0.45% Sodium Chloride Injection USP (10 mEq K⁺/liter)
	0264-7634-00	L6340	1000 mL
0.15% Potassium Chloride in 5% Dextrose and 0.45% Sodium Chloride Injection USP (20 mEq K⁺/liter)
01931547	0264-7635-00	L6350	1000 mL
0.22% Potassium Chloride in 5% Dextrose and 0.45% Sodium Chloride Injection USP (30 mEq K⁺/liter)
	0264-7636-00	L6360	1000 mL
0.30% Potassium Chloride in 5% Dextrose and 0.45% Sodium Chloride Injection USP (40 mEq K⁺/liter)
01931571	0264-7638-00	L6380	1000 mL
0.15% Potassium Chloride in 5% Dextrose and 0.9% Sodium Chloride Injection USP (20 mEq K⁺/liter)
01931644	0264-7652-00	L6520	1000 mL

STORAGE AND HANDLING SECTION

Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. Protect from freezing. It is recommended that the product be stored at room temperature (25°C).

SPL UNCLASSIFIED SECTION

Rx only

Revised: June 2023

EXCEL is a registered trademark of B. Braun Medical Inc.

Directions for Use of EXCEL Container

SPL PATIENT PACKAGE INSERT SECTION

Caution: Do not use plastic containers in series connection.

To Open

Tear overwrap down at notch and remove solution container.
Check for minute leaks by squeezing solution container firmly.
If leaks are found, discard solution as sterility may be impaired.
If supplemental medication is desired, follow directions below before preparing for administration.

NOTE: Before use, perform the following checks:

Inspect each container. Read the label. Ensure solution is the one ordered and is within the expiration date.
Invert container and carefully inspect the solution in good light for cloudiness, haze, or particulate matter. Any container which is suspect should not be used.
Use only if solution is clear and container and seals are intact.

Preparation for Administration

Remove plastic protector from sterile set port at bottom of container.
Attach administration set. Refer to complete directions accompanying set.

To Add Medication

Warning: Some additives may be incompatible.

To Add Medication Before Solution Administration

Prepare medication site.
Using syringe with 18–22 gauge needle, puncture medication port and inner diaphragm and inject.
Squeeze and tap ports while ports are upright and mix solution and medication thoroughly.

To Add Medication During Solution Administration

Close clamp on the set.
Prepare medication site.
Using syringe with 18–22 gauge needle of appropriate length (at least 5/8 inch), puncture resealable medication port and inner diaphragm and inject.
Remove container from IV pole and/or turn to an upright position.
Evacuate both ports by tapping and squeezing them while container is in the upright position.
Mix solution and medication thoroughly.
Return container to in use position and continue administration.

SPL UNCLASSIFIED SECTION

B. Braun Medical Inc.
Bethlehem, PA 18018-3524 USA
1-800-227-2862

In Canada, distributed by:
B. Braun of Canada, Ltd.
Scarborough, Ontario M1H 2W4

Y36-003-066 LD-196-5

PRINCIPAL DISPLAY PANEL - 1000 mL Container Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

0.075% Potassium Chloride in
5% Dextrose and
0.45% Sodium Chloride
Injection USP

REF L6340
NDC 0264-7634-00

1000 mL
EXCEL^®CONTAINER

10 mEq K⁺/liter
Y94-003-346 LD-258-3

Each 100 mL contains: Hydrous Dextrose USP 5 g; Sodium
Chloride USP 0.45 g; Potassium Chloride USP 0.075 g; Water
for Injection USP qs

pH: 4.4 (3.5-6.5); Calc. Osmolarity: 425 mOsmol/liter,
hypertonic

Electrolytes (mEq/liter): Na⁺77; K⁺10; Cl^–87

Sterile, nonpyrogenic. Single dose container. Do not use in series
connection. For intravenous use only. Use only if solution is clear
and container and seals are intact.

WARNINGS: Some additives may be incompatible. Consult with
pharmacist. When introducing additives, use aseptic techniques.
Mix thoroughly. Do not store.

Recommended Storage: Room temperature (25°C). Avoid
excessive heat. Protect from freezing. See Package Insert.

Do not remove overwrap until ready for use. After removing the overwrap,
check for minute leaks by squeezing container firmly. If leaks are found,
discard solution as sterility may be impaired.

Not made with natural rubber latex, PVC or DEHP.

Rx only
Recycle 7
EXCEL is a registered trademark of B. Braun Medical Inc.

B. Braun Medical Inc.
Bethlehem, PA 18018-3524 USA
1-800-227-2862

Y94-003-285
LD-166-3

EXP LOT

PRINCIPAL DISPLAY PANEL - 1000 mL Container Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

0.15% Potassium Chloride in
5% Dextrose and
0.45% Sodium Chloride
Injection USP

REF L6350
NDC 0264-7635-00
DIN 01931547
SG SIN13887P

1000 mL
EXCEL^®CONTAINER

20 mEq K⁺/liter
Y94-003-347 LD-265-4

Each 100 mL contains: Hydrous Dextrose USP 5 g; Sodium
Chloride USP 0.45 g; Potassium Chloride USP 0.15 g; Water
for Injection USP qs

pH: 4.4 (3.5-6.5); Calc. Osmolarity: 445 mOsmol/liter,
hypertonic

Electrolytes (mEq/liter): Na⁺77; K⁺20; Cl^–97

Sterile, nonpyrogenic. Single dose container. Do not use in series
connection. For intravenous use only. Use only if solution is clear
and container and seals are intact.

WARNINGS: Some additives may be incompatible. Consult with
pharmacist. When introducing additives, use aseptic techniques.
Mix thoroughly. Do not store.

Recommended Storage: Room temperature (25°C). Avoid excessive
heat. Protect from freezing. See Package Insert.

Do not remove overwrap until ready for use. After removing the overwrap,
check for minute leaks by squeezing container firmly. If leaks are found,
discard solution as sterility may be impaired.

Not made with natural rubber latex, PVC or DEHP.

Rx only
Recycle 7

EXCEL is a registered trademark of B. Braun Medical Inc.

B. Braun Medical Inc.
Bethlehem, PA 18018-3524 USA
1-800-227-2862

In Canada, distributed by:
B. Braun of Canada, Ltd.
Scarborough, Ontario M1H 2W4

Y94-003-493
LD-158-6

EXP LOT

PRINCIPAL DISPLAY PANEL - 1000 mL Container Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

0.22% Potassium Chloride in
5% Dextrose and
0.45% Sodium Chloride
Injection USP

REF L6360
NDC 0264-7636-00
SG SIN13888P

1000 mL
EXCEL^® CONTAINER

30 mEq K⁺/liter
Y94-003-348 LD-266-3

Each 100 mL contains: Hydrous Dextrose USP 5 g; Sodium
Chloride USP 0.45 g; Potassium Chloride USP 0.22 g; Water
for Injection USP qs

pH: 4.4 (3.5-6.5); Calc. Osmolarity: 465 mOsmol/liter,
hypertonic

Electrolytes (mEq/liter): Na⁺ 77; K⁺ 30; Cl^– 107

Sterile, nonpyrogenic. Single dose container. Do not use in series
connection. For intravenous use only. Use only if solution is clear
and container and seals are intact.

WARNINGS: Some additives may be incompatible. Consult with
pharmacist. When introducing additives, use aseptic techniques.
Mix thoroughly. Do not store.

Recommended Storage: Room temperature (25°C). Avoid excessive
heat. Protect from freezing. See Package Insert.

Do not remove overwrap until ready for use. After removing the overwrap,
check for minute leaks by squeezing container firmly. If leaks are found,
discard solution as sterility may be impaired.

Not made with natural rubber latex, PVC or DEHP.

Rx only
Recycle 7

EXCEL is a registered trademark of B. Braun Medical Inc.

B. Braun Medical Inc.
Bethlehem, PA 18018-3524 USA
1-800-227-2862

Y94-003-494
LD-157-5

EXP LOT

PRINCIPAL DISPLAY PANEL - 1000 mL Container Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

0.30% Potassium Chloride in
5% Dextrose and
0.45% Sodium Chloride
Injection USP

REF L6380
NDC 0264-7638-00
DIN 01931571
SG SIN13889P

1000 mL
EXCEL^® CONTAINER

40 mEq K⁺/liter
Y94-003-349 LD-274-3

Each 100 mL contains: Hydrous Dextrose USP 5 g; Sodium
Chloride USP 0.45 g; Potassium Chloride USP 0.3 g; Water
for Injection USP qs

pH: 4.4 (3.5-6.5); Calc. Osmolarity: 490 mOsmol/liter,
hypertonic

Electrolytes (mEq/liter): Na⁺ 77; K⁺ 40; Cl^– 117

Sterile, nonpyrogenic. Single dose container. Do not use in series
connection. For intravenous use only. Use only if solution is clear
and container and seals are intact.

WARNINGS: Some additives may be incompatible. Consult with
pharmacist. When introducing additives, use aseptic techniques.
Mix thoroughly. Do not store.

Recommended Storage: Room temperature (25°C). Avoid excessive
heat. Protect from freezing. See Package Insert.

Do not remove overwrap until ready for use. After removing the overwrap,
check for minute leaks by squeezing container firmly. If leaks are found,
discard solution as sterility may be impaired.

Not made with natural rubber latex, PVC or DEHP.

Rx only
Recycle 7

EXCEL is a registered trademark of B. Braun Medical Inc.

B. Braun Medical Inc.
Bethlehem, PA 18018-3524 USA
1-800-227-2862

In Canada, distributed by:
B. Braun of Canada, Ltd.
Scarborough, Ontario M1H 2W4

Y94-003-495
LD-156-5

EXP LOT

PRINCIPAL DISPLAY PANEL - 1000 mL Container Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

0.15% Potassium Chloride in
5% Dextrose and
0.20% Sodium Chloride
Injection USP

REF L6450
NDC 0264-7645-00
DIN 01931598

1000 mL
EXCEL^®CONTAINER

20 mEq K⁺/liter
Y94-003-350 LD-506-2

Each 100 mL contains: Hydrous Dextrose USP 5 g; Sodium
Chloride USP 0.2 g; Potassium Chloride USP 0.15 g; Water
for Injection USP qs

pH: 4.4 (3.5-6.5); Calc. Osmolarity: 360 mOsmol/liter,
hypertonic

Electrolytes (mEq/liter): Na⁺34; K⁺20; Cl^–54

Sterile, nonpyrogenic. Single dose container. Do not use in series
connection. For intravenous use only. Use only if solution is clear
and container and seals are intact.

WARNINGS: Some additives may be incompatible. Consult with
pharmacist. When introducing additives, use aseptic techniques.
Mix thoroughly. Do not store.

Recommended Storage: Room temperature (25°C). Avoid
excessive heat. Protect from freezing. See Package Insert.

Do not remove overwrap until ready for use. After removing the overwrap,
check for minute leaks by squeezing container firmly. If leaks are found,
discard solution as sterility may be impaired.

Not made with natural rubber latex, PVC or DEHP.

Rx only
Recycle 7

EXCEL is a registered trademark of B. Braun Medical Inc.

B. Braun Medical Inc.
Bethlehem, PA 18018-3524 USA
1-800-227-2862

In Canada, distributed by:
B. Braun of Canada, Ltd.
Scarborough, Ontario M1H 2W4

Y94-003-279
LD-163-3

EXP LOT

PRINCIPAL DISPLAY PANEL - 1000 mL Container Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

0.15% Potassium Chloride in
5% Dextrose and
0.9% Sodium Chloride
Injection USP

REF L6520
NDC 0264-7652-00
DIN 01931644
SG SIN13886P

1000 mL
EXCEL^®CONTAINER

20 mEq K⁺/liter
Y94-003-351 LD-504-2

Each 100 mL contains: Hydrous Dextrose USP 5 g; Sodium
Chloride USP 0.9 g; Potassium Chloride USP 0.15 g; Water
for Injection USP qs

pH: 4.4 (3.5-6.5); Calc. Osmolarity: 600 mOsmol/liter,
hypertonic

Electrolytes (mEq/liter): Na⁺154; K⁺20; Cl^–174

Sterile, nonpyrogenic. Single dose container. Do not use in series
connection. For intravenous use only. Use only if solution is clear
and container and seals are intact.

WARNINGS: Some additives may be incompatible. Consult with
pharmacist. When introducing additives, use aseptic techniques.
Mix thoroughly. Do not store.

Recommended Storage: Room temperature (25°C). Avoid
excessive heat. Protect from freezing. See Package Insert.

Do not remove overwrap until ready for use. After removing the overwrap,
check for minute leaks by squeezing container firmly. If leaks are found,
discard solution as sterility may be impaired.

Not made with natural rubber latex, PVC or DEHP.

Rx only
Recycle 7

EXCEL is a registered trademark of B. Braun Medical Inc.

B. Braun Medical Inc.
Bethlehem, PA 18018-3524 USA
1-800-227-2862

In Canada, distributed by:
B. Braun of Canada, Ltd.
Scarborough, Ontario M1H 2W4

Y94-003-496
LD-155-5

EXP LOT

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
630796	potassium chloride 10 MEQ / dextrose 5 % / sodium chloride 0.45 % per 1000 ML Injection	PSN	23
1863973	potassium chloride 20 MEQ / dextrose 5 % / sodium chloride 0.225 % in 1000 ML Injection	PSN	23
1863988	potassium chloride 20 MEQ / dextrose 5 % / sodium chloride 0.3 % in 1000 ML Injection	PSN	23
1863605	potassium chloride 20 MEQ / dextrose 5 % / sodium chloride 0.45 % in 1000 ML Injection	PSN	23
615107	potassium chloride 20 MEQ / dextrose 5 % / sodium chloride 0.9 % in 1000 ML Injection	PSN	23
615099	potassium chloride 30 MEQ / dextrose 5 % / sodium chloride 0.45 % in 1000 ML Injection	PSN	23
615100	potassium chloride 40 MEQ / dextrose 5 % / sodium chloride 0.45 % in 1000 ML Injection	PSN	23
1866190	potassium chloride 5 MEQ / dextrose 5 % / sodium chloride 0.225 % per 250 ML Injection	PSN	23
630796	1000 ML glucose 50 MG/ML / potassium chloride 0.01 MEQ/ML / sodium chloride 4.5 MG/ML Injection	SCD	23
1863973	1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 2.25 MG/ML Injection	SCD	23
1863988	1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 3 MG/ML Injection	SCD	23
1863605	1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection	SCD	23
615107	1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection	SCD	23
615099	1000 ML glucose 50 MG/ML / potassium chloride 0.03 MEQ/ML / sodium chloride 4.5 MG/ML Injection	SCD	23
615100	1000 ML glucose 50 MG/ML / potassium chloride 0.04 MEQ/ML / sodium chloride 4.5 MG/ML Injection	SCD	23
1866190	250 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 2.25 MG/ML Injection	SCD	23
630796	1000 ML Glucose 50 MG/ML / K+ Chloride 0.01 MEQ/ML / NaCl 4.5 MG/ML Injection	SY	23
1863973	1000 ML Glucose 50 MG/ML / K+ Chloride 0.02 MEQ/ML / NaCl 2.25 MG/ML Injection	SY	23
1863988	1000 ML Glucose 50 MG/ML / K+ Chloride 0.02 MEQ/ML / NaCl 3 MG/ML Injection	SY	23
1863605	1000 ML Glucose 50 MG/ML / K+ Chloride 0.02 MEQ/ML / NaCl 4.5 MG/ML Injection	SY	23
615107	1000 ML Glucose 50 MG/ML / K+ Chloride 0.02 MEQ/ML / NaCl 9 MG/ML Injection	SY	23
615099	1000 ML Glucose 50 MG/ML / K+ Chloride 0.03 MEQ/ML / NaCl 4.5 MG/ML Injection	SY	23
615100	1000 ML Glucose 50 MG/ML / K+ Chloride 0.04 MEQ/ML / NaCl 4.5 MG/ML Injection	SY	23
630796	1000 ML Glucose 50 MG/ML / Pot Chloride 0.01 MEQ/ML / NaCl 4.5 MG/ML Injection	SY	23
1863973	1000 ML Glucose 50 MG/ML / Pot Chloride 0.02 MEQ/ML / NaCl 2.25 MG/ML Injection	SY	23
1863988	1000 ML Glucose 50 MG/ML / Pot Chloride 0.02 MEQ/ML / NaCl 3 MG/ML Injection	SY	23
1863605	1000 ML Glucose 50 MG/ML / Pot Chloride 0.02 MEQ/ML / NaCl 4.5 MG/ML Injection	SY	23
615107	1000 ML Glucose 50 MG/ML / Pot Chloride 0.02 MEQ/ML / NaCl 9 MG/ML Injection	SY	23
615099	1000 ML Glucose 50 MG/ML / Pot Chloride 0.03 MEQ/ML / NaCl 4.5 MG/ML Injection	SY	23
615100	1000 ML Glucose 50 MG/ML / Pot Chloride 0.04 MEQ/ML / NaCl 4.5 MG/ML Injection	SY	23
1866190	250 ML Glucose 50 MG/ML / K+ Chloride 0.02 MEQ/ML / NaCl 2.25 MG/ML Injection	SY	23
1866190	250 ML Glucose 50 MG/ML / Pot Chloride 0.02 MEQ/ML / NaCl 2.25 MG/ML Injection	SY	23
630796	potassium chloride 10 MEQ / dextrose 5 % / sodium chloride 0.45 % per 1000 ML Injection	SY	23
1863973	potassium chloride 20 MEQ / dextrose 5 % / sodium chloride 0.225 % per 1000 ML Injection	SY	23
1863988	potassium chloride 20 MEQ / dextrose 5 % / sodium chloride 0.3 % per 1000 ML Injection	SY	23
1863605	potassium chloride 20 MEQ / dextrose 5 % / sodium chloride 0.45 % per 1000 ML Injection	SY	23
615107	potassium chloride 20 MEQ / dextrose 5 % / sodium chloride 0.9 % per 1000 ML Injection	SY	23
615099	potassium chloride 30 MEQ / dextrose 5 % / sodium chloride 0.45 % per 1000 ML Injection	SY	23
615100	potassium chloride 40 MEQ / dextrose 5 % / sodium chloride 0.45 % per 1000 ML Injection	SY	23
1866190	potassium chloride 5 MEQ / dextrose 5 % / sodium chloride 0.225 % per 250 ML Injection	SY	23

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
POTASSIUM CATION Pharmacologic Class Indexing	3	Indexing - Pharmacologic Class	20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
9e37788c-b1bf-42ae-aac9-b60601606144	Product name	8	20260122
95250459-30e4-45c1-b08a-993044f49109	Product name	2	20250805
d9771140-739b-484b-ae64-b79528ff1211	Product name	3	20250801
efd58dcf-540a-4531-8766-e713129ca6f2	Product name	1	20250307
30b0ac6e-02aa-0e5c-0d8b-cffdf3a282b2	Product name	5	20250304
726062af-1135-4707-a1d7-57256991bbf9	Product name	2	20250226
1527ac37-808d-43be-a63e-74e1258dbe46	Product name	9	20250219
a21a21e5-f36d-4c1f-8918-def921b8f7e3	Product name	3	20250124
bed0530e-f939-4541-956b-6928a2f6404f	Product name	1	20241008
cefa60e2-a5b5-493e-9c54-24735b7dc509	Product name	6	20240814
fb7ab793-2c12-4079-b100-a64f73bef25a	Product name	4	20240712
362d7abb-94e6-4c60-9a58-266894157713	Product name	1	20231023
b0cbf770-6cc3-4aa4-9158-755110c2b9f7	Product name	2	20230717
cb89b86a-369e-4204-8910-ae797c503af3	Product name	1	20230706
dc7c5daa-021f-40dd-b00d-63982cb2067a	Product name	1	20230426
9fcb7a91-de07-4f00-aabf-e4d6fda403d5	Product name	8	20230322
6bd95106-a412-1dad-b9cc-4cb74bfb27ce	Product name	2	20230315
f1e0dc7e-7d61-4625-b6d9-4894927679d7	Product name	2	20211025
9badc7be-250a-44ab-aa36-926af3f02679	Product name	1	20210527
08ffbcbf-26df-b99c-1dab-64fc4cfae89f	Product name	5	20200925
e4870509-7e28-6f92-f0be-dd3dd889a9cf	Product name	5	20200810
0ec3537a-6c9b-432a-896c-b9ea8723049a	Product name	9	20200701
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cd	Product name	2	20190619
444b3e50-f226-46ef-bfca-2e7035d140cd	Product name	1	20190611
816b97af-edc5-4060-aff1-b814bdbcad50	Product name	1	20190415
d4880ace-a516-8c47-8dfd-73a4ba5887d7	Product name	2	20180830
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
7916de40-e296-41f0-b811-6d0df1a33e2c	Product name	9	20180627
cefa60e2-a5b5-493e-9c54-24735b7dc509	Product name	2	20171212
419aab54-5d5a-4146-9453-026d4a9991be	Product name	2	20170525
26acd337-b838-40ac-bcbc-05c3b81c8712	Product name	1	20170323
08ffbcbf-26df-b99c-1dab-64fc4cfae89f	Product name	2	20160823
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
290f523a-f9db-9774-b5a9-e1f908ac1782	Product name	1	20150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316
19c71a3d-ed9c-166b-a7e5-38c250c35631	Product name	1	20140508
5668b646-cd56-c3c7-bdea-3f6b1a8840db	Product name	1	20140508
597b1cfd-7b31-5048-62be-ca5cd740da2f	Product name	1	20140508
684ea482-2e8b-14af-5664-b98f1e402036	Product name	1	20140508
810ab97e-f109-f41c-7c83-6a652a9cbf43	Product name	1	20140508
87711080-88eb-65c5-b2dd-bf99e700a372	Product name	1	20140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2dd	Product name	1	20140508
b060cc1a-fe47-856b-0b77-4448b5963de8	Product name	1	20140508
c6b65c52-69c7-df49-550a-a50c137f6218	Product name	1	20140508
ec2149b3-5c6d-5344-f757-c86411073075	Product name	1	20140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
0264-7634-00	Potassium Chloride in Dextrose and Sodium Chloride	1000 mL in 1 CONTAINER	INJECTION	1000	23
0264-7634-00	Potassium Chloride in Dextrose and Sodium Chloride	12 in 1 CASE	INJECTION	12	23
0264-7635-00	Potassium Chloride in Dextrose and Sodium Chloride	12 in 1 CASE	INJECTION	12	23
0264-7635-00	Potassium Chloride in Dextrose and Sodium Chloride	1000 mL in 1 CONTAINER	INJECTION	1000	23
0264-7636-00	Potassium Chloride in Dextrose and Sodium Chloride	1000 mL in 1 CONTAINER	INJECTION	1000	23
0264-7636-00	Potassium Chloride in Dextrose and Sodium Chloride	12 in 1 CASE	INJECTION	12	23
0264-7638-00	Potassium Chloride in Dextrose and Sodium Chloride	1000 mL in 1 CONTAINER	INJECTION	1000	23
0264-7638-00	Potassium Chloride in Dextrose and Sodium Chloride	12 in 1 CASE	INJECTION	12	23
0264-7645-00	Potassium Chloride in Dextrose and Sodium Chloride	1000 mL in 1 CONTAINER	INJECTION	1000	23
0264-7645-00	Potassium Chloride in Dextrose and Sodium Chloride	12 in 1 CASE	INJECTION	12	23
0264-7645-10	Potassium Chloride in Dextrose and Sodium Chloride	500 mL in 1 CONTAINER	INJECTION	500	23
0264-7645-10	Potassium Chloride in Dextrose and Sodium Chloride	24 in 1 CASE	INJECTION	24	23
0264-7645-20	Potassium Chloride in Dextrose and Sodium Chloride	24 in 1 CASE	INJECTION	24	23
0264-7645-20	Potassium Chloride in Dextrose and Sodium Chloride	250 mL in 1 CONTAINER	INJECTION	250	23
0264-7652-00	Potassium Chloride in Dextrose and Sodium Chloride	12 in 1 CASE	INJECTION	12	23
0264-7652-00	Potassium Chloride in Dextrose and Sodium Chloride	1000 mL in 1 CONTAINER	INJECTION	1000	23
0264-7655-00	Potassium Chloride in Dextrose and Sodium Chloride	1000 mL in 1 CONTAINER	INJECTION	1000	23
0264-7655-00	Potassium Chloride in Dextrose and Sodium Chloride	12 in 1 CASE	INJECTION	12	23

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0264-7634	POTASSIUM CHLORIDE IN DEXTROSE AND SODIUM CHLORIDE (DEXTROSE, SODIUM CHLORIDE, AND POTASSIUM CHLORIDE) INJECTION [B. BRAUN MEDICAL INC.]	23	Current NDC, Legacy NDC, 2 package rows	20240328_59ccc717-c374-41c0-be58-9647df881160.zip
0264-7635	POTASSIUM CHLORIDE IN DEXTROSE AND SODIUM CHLORIDE (DEXTROSE, SODIUM CHLORIDE, AND POTASSIUM CHLORIDE) INJECTION [B. BRAUN MEDICAL INC.]	23	Current NDC, Legacy NDC, 2 package rows	20240328_59ccc717-c374-41c0-be58-9647df881160.zip
0264-7636	POTASSIUM CHLORIDE IN DEXTROSE AND SODIUM CHLORIDE (DEXTROSE, SODIUM CHLORIDE, AND POTASSIUM CHLORIDE) INJECTION [B. BRAUN MEDICAL INC.]	23	Current NDC, Legacy NDC, 2 package rows	20240328_59ccc717-c374-41c0-be58-9647df881160.zip
0264-7638	POTASSIUM CHLORIDE IN DEXTROSE AND SODIUM CHLORIDE (DEXTROSE, SODIUM CHLORIDE, AND POTASSIUM CHLORIDE) INJECTION [B. BRAUN MEDICAL INC.]	23	Current NDC, Legacy NDC, 2 package rows	20240328_59ccc717-c374-41c0-be58-9647df881160.zip
0264-7645	POTASSIUM CHLORIDE IN DEXTROSE AND SODIUM CHLORIDE (DEXTROSE, SODIUM CHLORIDE, AND POTASSIUM CHLORIDE) INJECTION [B. BRAUN MEDICAL INC.]	23	Current NDC, Legacy NDC, 6 package rows	20240328_59ccc717-c374-41c0-be58-9647df881160.zip
0264-7652	POTASSIUM CHLORIDE IN DEXTROSE AND SODIUM CHLORIDE (DEXTROSE, SODIUM CHLORIDE, AND POTASSIUM CHLORIDE) INJECTION [B. BRAUN MEDICAL INC.]	23	Current NDC, Legacy NDC, 2 package rows	20240328_59ccc717-c374-41c0-be58-9647df881160.zip
0264-7655	POTASSIUM CHLORIDE IN DEXTROSE AND SODIUM CHLORIDE (DEXTROSE, SODIUM CHLORIDE, AND POTASSIUM CHLORIDE) INJECTION [B. BRAUN MEDICAL INC.]	23	Legacy NDC, 2 package rows	20240328_59ccc717-c374-41c0-be58-9647df881160.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0264-7645-00	ML - Milliliter	0264-7645	1c5a0a16-5659-455b-a7cc-64635c1ec1e5	1	2012-07-24
0264-7645-20	ML - Milliliter	0264-7645	dfce90ac-21f5-408a-8203-1e815b43b513	1	2012-07-24
0264-7655-00	ML - Milliliter	0264-7655	3a7974b4-6362-4e84-829b-c6d3afe37618	1	2012-07-24
0264-7634-00	ML - Milliliter	0264-7634	2f8c40b6-5b76-4507-a966-f7220367596f	1	2012-07-24
0264-7635-00	ML - Milliliter	0264-7635	ea43e385-feb7-4a15-8778-1c29795dd1ce	1	2012-07-24
0264-7636-00	ML - Milliliter	0264-7636	ed195f5b-9ce5-439f-8547-9bb48e6817a4	1	2012-07-24
0264-7638-00	ML - Milliliter	0264-7638	cac5ed0b-b4ed-4b51-b088-f03a5782f934	1	2012-07-24
0264-7652-00	ML - Milliliter	0264-7652	a1a82ee3-8bc4-4f73-928b-a3921ffce3fe	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
DEXTROSE	ACTIVE INGREDIENT	IY9XDZ35W2	9
POTASSIUM CHLORIDE	ACTIVE INGREDIENT	660YQ98I10	9
SODIUM CHLORIDE	ACTIVE INGREDIENT	451W47IQ8X	9
DEXTROSE	ACTIVE MOIETY	IY9XDZ35W2	9
POTASSIUM CATION	ACTIVE MOIETY	295O53K152	9
SODIUM CATION	ACTIVE MOIETY	LYR4M0NH37	9
WATER	INACTIVE INGREDIENT	059QF0KO0R	9

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

Potassium Chloride in Dextrose and Sodium Chloride
DEXTROSE, SODIUM CHLORIDE, and POTASSIUM CHLORIDE
DEXTROSE, UNSPECIFIED FORM
ANHYDROUS DEXTROSE
SODIUM CHLORIDE
SODIUM CATION
CHLORIDE ION
POTASSIUM CHLORIDE
POTASSIUM CATION
WATER

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
0264-7645	0264-7645-00, 0264-7645-10, 0264-7645-20
0264-7655	0264-7655-00
0264-7634	0264-7634-00
0264-7635	0264-7635-00
0264-7636	0264-7636-00
0264-7638	0264-7638-00
0264-7652	0264-7652-00

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 28 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
DEXTROSE, UNSPECIFIED FORM	IY9XDZ35W2	ACTIB
SODIUM CHLORIDE	451W47IQ8X	ACTIB
POTASSIUM CHLORIDE	660YQ98I10	ACTIB
WATER	059QF0KO0R	IACT
DEXTROSE, UNSPECIFIED FORM	IY9XDZ35W2	ACTIB
SODIUM CHLORIDE	451W47IQ8X	ACTIB
POTASSIUM CHLORIDE	660YQ98I10	ACTIB
WATER	059QF0KO0R	IACT
DEXTROSE, UNSPECIFIED FORM	IY9XDZ35W2	ACTIB
SODIUM CHLORIDE	451W47IQ8X	ACTIB
POTASSIUM CHLORIDE	660YQ98I10	ACTIB
WATER	059QF0KO0R	IACT
DEXTROSE, UNSPECIFIED FORM	IY9XDZ35W2	ACTIB
SODIUM CHLORIDE	451W47IQ8X	ACTIB
POTASSIUM CHLORIDE	660YQ98I10	ACTIB
WATER	059QF0KO0R	IACT
DEXTROSE, UNSPECIFIED FORM	IY9XDZ35W2	ACTIB
SODIUM CHLORIDE	451W47IQ8X	ACTIB
POTASSIUM CHLORIDE	660YQ98I10	ACTIB
WATER	059QF0KO0R	IACT
DEXTROSE, UNSPECIFIED FORM	IY9XDZ35W2	ACTIB
SODIUM CHLORIDE	451W47IQ8X	ACTIB
POTASSIUM CHLORIDE	660YQ98I10	ACTIB
WATER	059QF0KO0R	IACT
DEXTROSE, UNSPECIFIED FORM	IY9XDZ35W2	ACTIB
SODIUM CHLORIDE	451W47IQ8X	ACTIB
POTASSIUM CHLORIDE	660YQ98I10	ACTIB
WATER	059QF0KO0R	IACT

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 53 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
N019630-001	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;37MG/100ML;110MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-002	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;75MG/100ML;110MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-003	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;110MG/100ML;110MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-004	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;150MG/100ML;110MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-005	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;220MG/100ML;110MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-006	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;300MG/100ML;110MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-007	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;37MG/100ML;200MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-008	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;75MG/100ML;200MG/100ML	INJECTABLE / INJECTION	AP	1988-02-17
N019630-009	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;110MG/100ML;200MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-010	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;150MG/100ML;200MG/100ML	INJECTABLE / INJECTION	AP	1988-02-17
N019630-011	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;220MG/100ML;200MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-012	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;300MG/100ML;200MG/100ML	INJECTABLE / INJECTION	AP	1988-02-17
N019630-013	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;37MG/100ML;330MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-014	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;75MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1988-02-17
N019630-015	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;110MG/100ML;330MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-016	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;150MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1988-02-17
N019630-017	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;220MG/100ML;330MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-018	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;300MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1988-02-17
N019630-019	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;37MG/100ML;450MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-020	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;75MG/100ML;450MG/100ML	INJECTABLE / INJECTION	AP	1988-02-17
N019630-021	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;110MG/100ML;450MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-022	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;150MG/100ML;450MG/100ML	INJECTABLE / INJECTION	AP	1988-02-17
N019630-023	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;220MG/100ML;450MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-024	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;300MG/100ML;450MG/100ML	INJECTABLE / INJECTION	AP	1988-02-17
N019630-025	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;37MG/100ML;900MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-026	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;75MG/100ML;900MG/100ML	INJECTABLE / INJECTION	AP	1988-02-17
N019630-027	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;110MG/100ML;900MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-028	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;150MG/100ML;900MG/100ML	INJECTABLE / INJECTION	AP	1988-02-17
N019630-029	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;220MG/100ML;900MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-030	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5GM/100ML;300MG/100ML;900MG/100ML	INJECTABLE / INJECTION	AP	1988-02-17
N019630-031	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	10GM/100ML;37MG/100ML;200MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-032	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	10GM/100ML;75MG/100ML;200MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-033	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	10GM/100ML;110MG/100ML;200MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-034	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	10GM/100ML;150MG/100ML;200MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-035	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	10GM/100ML;220MG/100ML;200MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-036	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	10GM/100ML;300MG/100ML;200MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-037	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	10GM/100ML;37MG/100ML;450MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-038	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	10GM/100ML;75MG/100ML;450MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-039	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	10GM/100ML;110MG/100ML;450MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-040	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	10GM/100ML;150MG/100ML;450MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-041	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	10GM/100ML;220MG/100ML;450MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-042	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	10GM/100ML;300MG/100ML;450MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-043	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	10GM/100ML;37MG/100ML;900MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-044	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	10GM/100ML;75MG/100ML;900MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-045	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	10GM/100ML;110MG/100ML;900MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-046	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	10GM/100ML;150MG/100ML;900MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-047	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	10GM/100ML;220MG/100ML;900MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-048	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	10GM/100ML;300MG/100ML;900MG/100ML	INJECTABLE / INJECTION		1988-02-17
N019630-049	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	3.3GM/100ML;75MG/100ML;300MG/100ML	INJECTABLE / INJECTION		1992-05-07
N019630-050	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	3.3GM/100ML;110MG/100ML;300MG/100ML	INJECTABLE / INJECTION		1992-05-07
N019630-051	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	3.3GM/100ML;150MG/100ML;300MG/100ML	INJECTABLE / INJECTION		1992-05-07
N019630-052	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	3.3GM/100ML;220MG/100ML;300MG/100ML	INJECTABLE / INJECTION		1992-05-07
N019630-053	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	3.3GM/100ML;300MG/100ML;300MG/100ML	INJECTABLE / INJECTION		1992-05-07

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 12 matching rows.

Application-product, TE code table
Application-product	TE code
N019630-008	AP
N019630-010	AP
N019630-012	AP
N019630-014	AP
N019630-016	AP
N019630-018	AP
N019630-020	AP
N019630-022	AP
N019630-024	AP
N019630-026	AP
N019630-028	AP
N019630-030	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 59 · 2,332 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	N019630-001	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	5GM/100ML;37MG/100ML;110MG/100ML	INJECTABLE / INJECTION		1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-002	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	5GM/100ML;75MG/100ML;110MG/100ML	INJECTABLE / INJECTION		1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-003	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	5GM/100ML;110MG/100ML;110MG/100ML	INJECTABLE / INJECTION		1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-004	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	5GM/100ML;150MG/100ML;110MG/100ML	INJECTABLE / INJECTION		1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-005	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	5GM/100ML;220MG/100ML;110MG/100ML	INJECTABLE / INJECTION		1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-006	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	5GM/100ML;300MG/100ML;110MG/100ML	INJECTABLE / INJECTION		1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-007	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	5GM/100ML;37MG/100ML;200MG/100ML	INJECTABLE / INJECTION		1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-008	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	5GM/100ML;75MG/100ML;200MG/100ML	INJECTABLE / INJECTION	AP	1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-009	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	5GM/100ML;110MG/100ML;200MG/100ML	INJECTABLE / INJECTION		1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-010	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	5GM/100ML;150MG/100ML;200MG/100ML	INJECTABLE / INJECTION	AP	1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-011	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	5GM/100ML;220MG/100ML;200MG/100ML	INJECTABLE / INJECTION		1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-012	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	5GM/100ML;300MG/100ML;200MG/100ML	INJECTABLE / INJECTION	AP	1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-013	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	5GM/100ML;37MG/100ML;330MG/100ML	INJECTABLE / INJECTION		1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-014	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	5GM/100ML;75MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-015	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	5GM/100ML;110MG/100ML;330MG/100ML	INJECTABLE / INJECTION		1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-016	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	5GM/100ML;150MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-017	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	5GM/100ML;220MG/100ML;330MG/100ML	INJECTABLE / INJECTION		1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-018	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	5GM/100ML;300MG/100ML;330MG/100ML	INJECTABLE / INJECTION	AP	1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-019	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	5GM/100ML;37MG/100ML;450MG/100ML	INJECTABLE / INJECTION		1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-020	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	5GM/100ML;75MG/100ML;450MG/100ML	INJECTABLE / INJECTION	AP	1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-021	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	5GM/100ML;110MG/100ML;450MG/100ML	INJECTABLE / INJECTION		1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-022	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	5GM/100ML;150MG/100ML;450MG/100ML	INJECTABLE / INJECTION	AP	1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-023	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	5GM/100ML;220MG/100ML;450MG/100ML	INJECTABLE / INJECTION		1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-024	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	5GM/100ML;300MG/100ML;450MG/100ML	INJECTABLE / INJECTION	AP	1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-025	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	5GM/100ML;37MG/100ML;900MG/100ML	INJECTABLE / INJECTION		1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-026	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	5GM/100ML;75MG/100ML;900MG/100ML	INJECTABLE / INJECTION	AP	1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-027	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	5GM/100ML;110MG/100ML;900MG/100ML	INJECTABLE / INJECTION		1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-028	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	5GM/100ML;150MG/100ML;900MG/100ML	INJECTABLE / INJECTION	AP	1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-029	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	5GM/100ML;220MG/100ML;900MG/100ML	INJECTABLE / INJECTION		1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-030	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	5GM/100ML;300MG/100ML;900MG/100ML	INJECTABLE / INJECTION	AP	1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-031	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	10GM/100ML;37MG/100ML;200MG/100ML	INJECTABLE / INJECTION		1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-032	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	10GM/100ML;75MG/100ML;200MG/100ML	INJECTABLE / INJECTION		1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-033	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	10GM/100ML;110MG/100ML;200MG/100ML	INJECTABLE / INJECTION		1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-034	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	10GM/100ML;150MG/100ML;200MG/100ML	INJECTABLE / INJECTION		1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-035	POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	10GM/100ML;220MG/100ML;200MG/100ML	INJECTABLE / INJECTION		1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-036	POTASSIUM CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER	10GM/100ML;300MG/100ML;200MG/100ML	INJECTABLE / INJECTION		1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-037	POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	10GM/100ML;37MG/100ML;450MG/100ML	INJECTABLE / INJECTION		1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-038	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	10GM/100ML;75MG/100ML;450MG/100ML	INJECTABLE / INJECTION		1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-039	POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	10GM/100ML;110MG/100ML;450MG/100ML	INJECTABLE / INJECTION		1988-02-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-040	POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	10GM/100ML;150MG/100ML;450MG/100ML	INJECTABLE / INJECTION		1988-02-17	`c2088c7a36db…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 14 · 528 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-10-15 13:18:30	2026-09	N019630-008	AP	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-010	AP	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-012	AP	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-014	AP	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-016	AP	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-018	AP	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-020	AP	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-022	AP	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-024	AP	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-026	AP	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-028	AP	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019630-030	AP	1	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	N019630-008	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N019630-010	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N019630-012	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N019630-014	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N019630-016	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N019630-018	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N019630-020	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N019630-022	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N019630-024	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N019630-026	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N019630-028	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N019630-030	AP	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N019630-008	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N019630-010	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N019630-012	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N019630-014	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N019630-016	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N019630-018	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N019630-020	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N019630-022	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N019630-024	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N019630-026	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N019630-028	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N019630-030	AP	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N019630-008	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N019630-010	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N019630-012	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N019630-014	AP	1	`011fe1cb6892…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Potassium Chloride in Dextrose and Sodium Chloride	DEXTROSE, SODIUM CHLORIDE, AND POTASSIUM CHLORIDE	B. Braun Medical Inc.	59ccc717-c374-41c0-be58-9647df881160	2024-03-26	Warnings, Adverse reactions	Exact identifier ndc (package): 0264-7655-00 ndc (package): 0264-7634-00 ndc (package): 0264-7645-10 ndc (package): 0264-7645-00 ndc (package): 0264-7636-00 ndc (package): 0264-7635-00 ndc (package): 0264-7645-20 ndc (package): 0264-7652-00 ndc (package): 0264-7638-00 ndc (product): 0264-7634 ndc (product): 0264-7645 ndc (product): 0264-7638 ndc (product): 0264-7655 ndc (product): 0264-7636 ndc (product): 0264-7652 ndc (product): 0264-7635 ndc11 (package): 00264764500 ndc11 (package): 00264763500 ndc11 (package): 00264764520 ndc11 (package): 00264764510 ndc11 (package): 00264765500 ndc11 (package): 00264763800 ndc11 (package): 00264763400 ndc11 (package): 00264765200 ndc11 (package): 00264763600 spl id: ed62bbc9-60b1-41c1-ae42-846cb79daa11 spl set id: 59ccc717-c374-41c0-be58-9647df881160

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.